These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
272 related items for PubMed ID: 8162349
1. Nontypeable Haemophilus influenzae disease: epidemiology, pathogenesis, and prospects for prevention. St Geme JW. Infect Agents Dis; 1993 Feb; 2(1):1-16. PubMed ID: 8162349 [Abstract] [Full Text] [Related]
2. Nontypeable Haemophilus influenzae as a pathogen in children. Murphy TF, Faden H, Bakaletz LO, Kyd JM, Forsgren A, Campos J, Virji M, Pelton SI. Pediatr Infect Dis J; 2009 Jan; 28(1):43-8. PubMed ID: 19057458 [Abstract] [Full Text] [Related]
3. New vaccines against otitis media: projected benefits and cost-effectiveness. O'Brien MA, Prosser LA, Paradise JL, Ray GT, Kulldorff M, Kurs-Lasky M, Hinrichsen VL, Mehta J, Colborn DK, Lieu TA. Pediatrics; 2009 Jun; 123(6):1452-63. PubMed ID: 19482754 [Abstract] [Full Text] [Related]
4. [Haemophilus influenzae b: a review on the determinants of pathogenicity and immune response to the infection]. Gómez de León P, Cabrera-Contreras R, Cravioto A. Salud Publica Mex; 1991 Jun; 33(5):504-12. PubMed ID: 1948428 [Abstract] [Full Text] [Related]
5. [Haemophilus influenzae infections in 2 hospitals in the city of Puebla, Mexico]. Sosa-Iglesias EG, González-Mancilla S, Juárez-Ahuactzi E, López-Merino A, Corona-Reyes D. Rev Latinoam Microbiol; 1995 Jun; 37(3):189-99. PubMed ID: 8850337 [Abstract] [Full Text] [Related]
6. Nontypeable Haemophilus influenzae: challenges in developing a vaccine. Kyd J, Cripps A. J Biotechnol; 1999 Aug 20; 73(2-3):103-8. PubMed ID: 10486920 [Abstract] [Full Text] [Related]
7. Role of nontypeable Haemophilus influenzae in pediatric respiratory tract infections. Klein JO. Pediatr Infect Dis J; 1997 Feb 20; 16(2 Suppl):S5-8. PubMed ID: 9041620 [Abstract] [Full Text] [Related]
8. Vaccine development for non-typeable Haemophilus influenzae and Moraxella catarrhalis: progress and challenges. Murphy TF. Expert Rev Vaccines; 2005 Dec 20; 4(6):843-53. PubMed ID: 16372880 [Abstract] [Full Text] [Related]
9. Nontypeable Haemophilus influenzae: understanding virulence and commensal behavior. Erwin AL, Smith AL. Trends Microbiol; 2007 Aug 20; 15(8):355-62. PubMed ID: 17600718 [Abstract] [Full Text] [Related]
10. [The role of Haemophilus influenzae in epidemiology of respiratory infection and meningitis]. Grzybowska W, Sawicki J. Przegl Epidemiol; 1995 Aug 20; 49(3):267-73. PubMed ID: 7491422 [Abstract] [Full Text] [Related]
11. Invasive Haemophilus influenzae disease in adults in Taiwan. Wang CC, Kuo HY, Chiang DH, Tsai CC, Lin ML, Chan YJ, Yang SP, Liu CY. J Microbiol Immunol Infect; 2008 Jun 20; 41(3):209-14. PubMed ID: 18629415 [Abstract] [Full Text] [Related]
12. Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now. Murphy TF. Clin Vaccine Immunol; 2015 May 20; 22(5):459-66. PubMed ID: 25787137 [Abstract] [Full Text] [Related]
13. Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines. Forsgren A, Riesbeck K, Janson H. Clin Infect Dis; 2008 Mar 01; 46(5):726-31. PubMed ID: 18230042 [Abstract] [Full Text] [Related]
14. Low rate of nasopharyngeal carriage and high rate of ampicillin resistance for Haemophilus influenzae among healthy children younger than 5 years old in northern Taiwan. Wang SR, Lo WT, Chou CY, Chen YY, Tsai SY, Chu ML, Wang CC. J Microbiol Immunol Infect; 2008 Feb 01; 41(1):32-40. PubMed ID: 18327424 [Abstract] [Full Text] [Related]
16. The pathogenicity of Haemophilus influenzae. Turk DC. J Med Microbiol; 1984 Aug 01; 18(1):1-16. PubMed ID: 6146721 [No Abstract] [Full Text] [Related]
17. [Progress toward molecular determinants of the pathogenesis of disease due to nontypeable Haemophilus influenzae]. Tian GZ, Zhang L, Shao ZJ. Zhongguo Yi Miao He Mian Yi; 2009 Apr 01; 15(2):174-9. PubMed ID: 20077666 [Abstract] [Full Text] [Related]
18. Invasive infections caused by haemophilus influenzae serotypes in twelve Canadian IMPACT centers, 1996-2001. McConnell A, Tan B, Scheifele D, Halperin S, Vaudry W, Law B, Embree J, of The Canadian Immunization Monitoring Program, ACTive (IMPACT). Pediatr Infect Dis J; 2007 Nov 01; 26(11):1025-31. PubMed ID: 17984810 [Abstract] [Full Text] [Related]
19. Polysaccharide vaccine for prevention of haemophilus influenzae type B disease. 1. Ky Nurse; 1985 Nov 01; 33(4):18-9. PubMed ID: 3875002 [No Abstract] [Full Text] [Related]